The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
Hybridization-based target enrichment panel with our intrinsic probe design, rebalancing, and molecular barcode technologies to efficiently analyze not only hard-to-capture areas but also challenging samples, such as damaged DNA or RNA.
View Detail >
End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >
Providing NGS-based diagnostics solutions for biopharma companies. Celemics can develop and deliver a flexible customization and commercialization services while maintaining the market-leading performance for our clients interested in clinical and companion diagnostics.
View Detail >
Tailored-fit customized assay development from designing to validation run; including not only the custom panel design but also species-specific or sequencer-specific blockers, followed by reagent conditioning to optimize the individual experiment and sequencer.
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
Find useful information, insights and tools for your Celemics’ products and services
View Detail >
Explore the most up-to-date publications featuring Celemics’ products and services
View Detail >
Sharing interesting stories about the world of NGS and how Celemics delivers the innovative NGS solutions to the world of science.
View Detail >
Explore a diverse range of engaging video content, from fascinating experiments showcasing cutting-edge research to heartfelt customer testimonials.
View Detail >Find useful information, insights and tools for your Celemics’ products and services
View Detail >
Stay up-to-date with the latest updates on our activities, events and achievements
View Detail >
Let’s change the NGS market together – our global presence and partners world-wide
View Detail >
Waiting for your experience with Celemics, an innovative leader in NGS industry
View Detail >Stay up-to-date with the latest updates on our activities, events and achievements
View Detail >Science is a collaborative process which works best when new knowledge is shared.
We contribute to this by presenting our research at scientific congresses and publishing our results in scientific journals.
Thaloengsakdadech, T., Triwutanon, S., Lertwatcharasarakul, P., Homwong, N., & Rukkwamsuk, T. (2026). Single-Nucleotide Polymorphisms in Calpastatin (CAST) and Micro-Calpain (CAPN1) Genes Influencing Meat Tenderness in Crossbred Beef Cattle in Thailand. Veterinary Sciences, 13(1), 99.
10.3390/vetsci13010099
Kim, Y. Y., Kim, M. S., Lee, S. H., & Choi, J. H. (2026). Pathogenic Variants and Clinical Outcomes in Korean Dilated Cardiomyopathy Patients: Insights From Next-Generation Sequencing. JACC: Asia, 6(5), 834-837.
10.1016/j.jacasi.2025.11.001
Nikolényi, A., Dobi, Á., Sántha, D., Kószó, R., Iványi, M., Horváth, E., … & Kahán, Z. (2026). Germline BRCA testing in routine clinical practice: a single-center experience. Pathology and Oncology Research, 32, 1612238.
10.3389/pore.2026.1612238
Surl, D., Choi, T. I., Park, J. W., Don, D. W., Kim, T. Y., Thomas, M. G., … & Kim, C. H. (2026). A Dosage-Dependent Dominant-Negative Mechanism of SLC45A2 (W74R) in Autosomal Dominant Oculocutaneous Albinism Revealed by Zebrafish Modeling. Translational Vision Science & Technology, 15(2), 22-22.
10.1167/tvst.15.2.22
Che, J., Kwon, W. S., Kim, J., Jadamba, E., Han, H. J., Kim, Y., … & Rha, S. Y. (2026). Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology. Scientific Reports.
10.1038/s41598-026-37991-0
